A $70m capital raising underway will help fund a number of acquisitions and allow PGC to continue effecting its consolidation strategy. The new businesses are expected to be accretive to earnings and we believe the integration risks are mitigated to a degree by successful execution to date. We maintain a buy call on a $1.20 valuation (prior $1.15).
To access our review of Paragon Care please log in under the Client Area Log In at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
+61 8 9224 6888
+852 3557 4888